Compare ORN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | PROF |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 243.2M |
| IPO Year | 2007 | 2017 |
| Metric | ORN | PROF |
|---|---|---|
| Price | $13.58 | $6.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $16.25 | $12.00 |
| AVG Volume (30 Days) | ★ 365.7K | 63.5K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | 25.89 |
| EPS | 0.12 | ★ 0.19 |
| Revenue | ★ $852,260,000.00 | $16,098,000.00 |
| Revenue This Year | $8.50 | $92.40 |
| Revenue Next Year | $7.83 | $64.10 |
| P/E Ratio | $118.25 | ★ $35.74 |
| Revenue Growth | 7.01 | ★ 50.73 |
| 52 Week Low | $6.44 | $3.92 |
| 52 Week High | $15.85 | $8.95 |
| Indicator | ORN | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 46.15 |
| Support Level | $13.20 | $6.54 |
| Resistance Level | $14.20 | $7.07 |
| Average True Range (ATR) | 0.66 | 0.29 |
| MACD | -0.17 | -0.05 |
| Stochastic Oscillator | 21.97 | 35.67 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.